These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9598798)

  • 21. The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation.
    Li G; Salhany KE; Rook AH; Lessin SR
    J Cutan Pathol; 1997 Aug; 24(7):403-8. PubMed ID: 9274957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS; Hardman DL; Boni R; Dummer R; Kim YH; Smoller BR; Takeshita M; Kikuchi M; Burg G
    Blood; 1996 Sep; 88(5):1765-70. PubMed ID: 8781433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
    Cataldo KA; Jalal SM; Law ME; Ansell SM; Inwards DJ; Fine M; Arber DA; Pulford KA; Strickler JG
    Am J Surg Pathol; 1999 Nov; 23(11):1386-92. PubMed ID: 10555007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype bearing the t(2;5)(p23;q35) translocation and presenting in a child.
    Gould JW; Eppes RB; Gilliam AC; Goldstein JA; Mikkola DL; Zaim MT; Wood GS
    Am J Dermatopathol; 2000 Oct; 22(5):422-8. PubMed ID: 11048978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease.
    Yee HT; Ponzoni M; Merson A; Goldstein M; Scarpa A; Chilosi M; Menestrina F; Pittaluga S; de Wolf-Peeters C; Shiota M; Mori S; Frizzera G; Inghirami G
    Blood; 1996 Feb; 87(3):1081-8. PubMed ID: 8562933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a 'small-cell variant' of ALCL.
    Lamant L; Espinos E; Duplantier M; Dastugue N; Robert A; Allouche M; Ragab J; Brousset P; Villalva C; Gascoyne RD; Al Saati T; Delsol G
    Leukemia; 2004 Oct; 18(10):1693-8. PubMed ID: 15356659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
    Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation.
    Lamant L; Dastugue N; Pulford K; Delsol G; Mariamé B
    Blood; 1999 May; 93(9):3088-95. PubMed ID: 10216106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology.
    Kansal R; Sait SN; Block AW; Ward PM; Kelly FL; Cheney RT; Czuczman M; Brecher ML; Barcos M
    Mod Pathol; 2005 Feb; 18(2):235-43. PubMed ID: 15475930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular cytogenetic aberrations in CD30+ anaplastic large cell lymphoma cell lines.
    Gogusev J; Telvi L; Nezelof C
    Cancer Genet Cytogenet; 2002 Oct; 138(2):95-101. PubMed ID: 12505251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
    J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases.
    Bayle C; Charpentier A; Duchayne E; Manel AM; Pages MP; Robert A; Lamant L; Dastugue N; Bertrand Y; Dijoud F; Emile JF; Machover D; Brugiéres L; Delsol G
    Br J Haematol; 1999 Mar; 104(4):680-8. PubMed ID: 10192426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new t(2;5) translocation in a null cell type CD30 positive anaplastic large cell lymphoma case.
    Wlodarska I; De Wolf-Peeters C; Michaux L; Mecucci C; Verhoef G; Cassiman JJ; Van den Berghe H
    Leukemia; 1995 Oct; 9(10):1685-8. PubMed ID: 7564510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. t(2;5) positive lymphoma with peripheral blood involvement.
    Chhanabhai M; Britten C; Klasa R; Gascoyne RD
    Leuk Lymphoma; 1998 Jan; 28(3-4):415-22. PubMed ID: 9517514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD30 and the NPM-ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma.
    Awaya N; Mori S; Takeuchi H; Mori S; Sugano Y; Kamata T; Takeuchi T; Abe T
    Am J Hematol; 2002 Mar; 69(3):200-4. PubMed ID: 11891807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
    Merkel O; Hamacher F; Griessl R; Grabner L; Schiefer AI; Prutsch N; Baer C; Egger G; Schlederer M; Krenn PW; Hartmann TN; Simonitsch-Klupp I; Plass C; Staber PB; Moriggl R; Turner SD; Greil R; Kenner L
    J Pathol; 2015 Aug; 236(4):445-56. PubMed ID: 25820993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three children with CD30 cutaneous anaplastic large cell lymphomas bearing the t(2;5)(p23;q35) translocation.
    Hinshaw M; Trowers AB; Kodish E; Kuerbitz S; Shurin S; Wood GS
    Pediatr Dermatol; 2004; 21(3):212-7. PubMed ID: 15165197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
    Sarris AH; Luthra R; Cabanillas F; Morris SW; Pugh WC
    Leuk Lymphoma; 1998 May; 29(5-6):507-14. PubMed ID: 9643564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALK-positive lymphoma: a single disease with a broad spectrum of morphology.
    Benharroch D; Meguerian-Bedoyan Z; Lamant L; Amin C; Brugières L; Terrier-Lacombe MJ; Haralambieva E; Pulford K; Pileri S; Morris SW; Mason DY; Delsol G
    Blood; 1998 Mar; 91(6):2076-84. PubMed ID: 9490693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.